Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-23

Clinical Trial Update: The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and effectiveness of calcipotriene foam in patients with scalp and body psoriasis has completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene foam (calcipotriene)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2011-09-23